Distinct Spatiotemporal Distribution of Bacterial Toxin-Produced Cellular cAMP Differentially Inhibits Opsonophagocytic Signaling.


Journal

Toxins
ISSN: 2072-6651
Titre abrégé: Toxins (Basel)
Pays: Switzerland
ID NLM: 101530765

Informations de publication

Date de publication:
20 06 2019
Historique:
received: 10 05 2019
revised: 12 06 2019
accepted: 18 06 2019
entrez: 23 6 2019
pubmed: 23 6 2019
medline: 17 3 2020
Statut: epublish

Résumé

Myeloid phagocytes have evolved to rapidly recognize invading pathogens and clear them through opsonophagocytic killing. The adenylate cyclase toxin (CyaA) of

Identifiants

pubmed: 31226835
pii: toxins11060362
doi: 10.3390/toxins11060362
pmc: PMC6628411
pii:
doi:

Substances chimiques

Adenylate Cyclase Toxin 0
Antigens, Bacterial 0
Bacterial Toxins 0
Opsonin Proteins 0
Receptors, Immunologic 0
anthrax toxin 0
opsonin receptor 0
Cyclic AMP E0399OZS9N

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Physiology (Bethesda). 2014 Mar;29(2):141-9
pubmed: 24583770
J Immunol. 2015 May 15;194(10):4901-13
pubmed: 25876760
FEBS Lett. 2006 Jul 24;580(17):4172-5
pubmed: 16828760
Infect Immun. 2009 Jun;77(6):2530-43
pubmed: 19307216
Cold Spring Harb Perspect Biol. 2012 Dec 01;4(12):
pubmed: 23209152
Scand J Immunol. 1977;6(8):797-807
pubmed: 561436
J Innate Immun. 2009;1(3):231-43
pubmed: 20375581
J Immunol. 2002 Aug 15;169(4):2003-9
pubmed: 12165526
Blood. 2006 Jun 1;107(11):4554-62
pubmed: 16449524
Immunity. 1996 Dec;5(6):591-604
pubmed: 8986718
Circ Res. 2008 Oct 10;103(8):836-44
pubmed: 18757829
Cell Biochem Biophys. 1998;28(2-3):251-75
pubmed: 9515168
Proc Natl Acad Sci U S A. 1982 May;79(10):3162-6
pubmed: 6285339
Cell Host Microbe. 2010 Nov 18;8(5):455-62
pubmed: 21075356
FEBS Lett. 1999 May 14;451(1):33-8
pubmed: 10356979
Immunity. 2016 Mar 15;44(3):463-475
pubmed: 26982354
J Exp Med. 1996 Aug 1;184(2):627-37
pubmed: 8760816
J Biol Chem. 1992 Nov 5;267(31):22599-605
pubmed: 1429610
J Vet Med Sci. 2016 Sep 1;78(8):1311-7
pubmed: 27170489
Pathog Dis. 2015 Nov;73(8):ftv075
pubmed: 26391732
PLoS Pathog. 2007 Dec;3(12):e187
pubmed: 18069891
Infect Immun. 2000 Jan;68(1):247-56
pubmed: 10603395
Proc Natl Acad Sci U S A. 1998 May 12;95(10):5752-6
pubmed: 9576956
Biomed Res Int. 2017;2017:9042851
pubmed: 28691037
PLoS Pathog. 2012;8(4):e1002580
pubmed: 22496638
Crit Rev Microbiol. 2004;30(3):187-96
pubmed: 15490970
Annu Rev Microbiol. 1995;49:239-76
pubmed: 8561460
J Immunol. 2005 Apr 15;174(8):4934-41
pubmed: 15814721
Toxins (Basel). 2016 Mar 10;8(3):
pubmed: 26978402
J Bacteriol. 1976 Aug;127(2):890-8
pubmed: 182669
EMBO J. 2006 Nov 15;25(22):5405-13
pubmed: 17082768
Mol Biol Cell. 2002 Apr;13(4):1215-26
pubmed: 11950933
J Immunol. 2008 Oct 15;181(8):5587-97
pubmed: 18832717
Infect Immun. 1985 Jan;47(1):306-10
pubmed: 3917427
J Immunol. 2005 Jan 15;174(2):595-9
pubmed: 15634874
J Cell Sci. 2006 Sep 1;119(Pt 17):3686-94
pubmed: 16931599
Biochem Soc Trans. 2006 Aug;34(Pt 4):495-7
pubmed: 16856842
J Innate Immun. 2016;8(5):437-51
pubmed: 26848986
PLoS Pathog. 2010 May 13;6(5):e1000901
pubmed: 20485565
FEBS Lett. 2005 Jun 13;579(15):3264-70
pubmed: 15943971
J Cell Biol. 2003 Feb 3;160(3):321-8
pubmed: 12551953
J Exp Med. 1997 Oct 6;186(7):1027-39
pubmed: 9314552
Exp Cell Res. 2008 Jan 15;314(2):255-63
pubmed: 18021770
Science. 1982 Sep 3;217(4563):948-50
pubmed: 6287574
PLoS One. 2008;3(10):e3564
pubmed: 18958164
PLoS Pathog. 2012 Jan;8(1):e1002481
pubmed: 22253596
Science. 2001 Jul 6;293(5527):98-101
pubmed: 11441182
Science. 1998 Nov 27;282(5394):1717-21
pubmed: 9831565
J Immunol. 2004 Jul 1;173(1):559-65
pubmed: 15210817
Elife. 2015 Dec 09;4:e10766
pubmed: 26650353
J Leukoc Biol. 2001 Aug;70(2):322-8
pubmed: 11493626
J Cell Biol. 2004 Jul 19;166(2):273-82
pubmed: 15249579
J Immunol. 2005 Jul 15;175(2):730-8
pubmed: 16002668
J Leukoc Biol. 2006 May;79(5):1073-82
pubmed: 16501050
Science. 1981 Jan 23;211(4480):407-10
pubmed: 6261328
Immunity. 2006 Mar;24(3):305-16
pubmed: 16546099
Toxins (Basel). 2017 Sep 24;9(10):
pubmed: 28946636
Sci Rep. 2016 Oct 31;6:36214
pubmed: 27796369
Front Immunol. 2018 May 01;9:919
pubmed: 29765373
Immunol Lett. 1995 Feb;45(1-2):1-4
pubmed: 7622175
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3242-7
pubmed: 14978283
J Immunol. 2017 Feb 1;198(3):1285-1296
pubmed: 28039302

Auteurs

Shakir Hasan (S)

Institute of Microbiology of the CAS, v. v. i., Videnska 1083, 142 20 Prague, Czech Republic. shakirhasan@gmail.com.

Waheed Ur Rahman (WU)

Institute of Microbiology of the CAS, v. v. i., Videnska 1083, 142 20 Prague, Czech Republic. waheed.rahman@biomed.cas.cz.

Peter Sebo (P)

Institute of Microbiology of the CAS, v. v. i., Videnska 1083, 142 20 Prague, Czech Republic. sebo@biomed.cas.cz.

Radim Osicka (R)

Institute of Microbiology of the CAS, v. v. i., Videnska 1083, 142 20 Prague, Czech Republic. osicka@biomed.cas.cz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH